Breaking News Instant updates and real-time market news.

SANA

Sana Biotechnology

$20.26 /

-0.52 (-2.50%)

, BEAM

Beam Therapeutics

$90.77 /

-2.33 (-2.50%)

09:08
10/19/21
10/19
09:08
10/19/21
09:08

Sana obtains non-exlusive license to CRISPR Cas12b gene editing technology

Sana Biotechnology (SANA) announced that the company entered into an agreement with Beam Therapeutics Inc. (BEAM) for non-exclusive commercial rights to Beam's CRISPR Cas12b nuclease system for certain ex vivo engineered cell therapy programs. Cas12b is a CRISPR-based nuclease with a high degree of specificity and efficiency that can be used to knock out and/or knock in genes in certain cell types. Under the agreement, Beam granted Sana non-exclusive rights to utilize its Cas12b system with certain allogeneic T cell and stem cell-derived programs, including the ability to make gene edits for Sana's hypoimmune platform. The license does not include any rights to base editing using Cas12b, which remain at Beam. Under the terms of the agreement, Sana agreed to pay Beam an upfront payment of $50 million. Beam is also eligible to receive certain target option exercise fees, certain milestone payments upon the achievement of certain development and sales milestones, and certain royalties on net sales of royalty-bearing products by Sana, its affiliates, its sublicensees and affiliates of its sublicensees.

SANA

Sana Biotechnology

$20.26 /

-0.52 (-2.50%)

BEAM

Beam Therapeutics

$90.77 /

-2.33 (-2.50%)

  • 04

    Feb

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Direxion Daily Russia Bull 3X Shares rises 13.4% » 12:00
01/27/22
01/27
12:00
01/27/22
12:00
RUSL

Direxion Daily Russia Bull 3X Shares

$20.49 /

+2.44 (+13.52%)

Direxion Daily Russia…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RUSL Direxion Daily Russia Bull 3X Shares
$20.49 /

+2.44 (+13.52%)

Recommendations
TransAlta Renewables price target lowered to C$18.50 from C$19 at Scotiabank » 11:58
01/27/22
01/27
11:58
01/27/22
11:58
TRSWF

TransAlta Renewables

$13.21 /

-0.07 (-0.53%)

Scotiabank analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRSWF TransAlta Renewables
$13.21 /

-0.07 (-0.53%)

01/12/22 National Bank
TransAlta Renewables price target lowered to C$18.50 from C$19 at National Bank
01/12/22 Raymond James
TransAlta Renewables price target lowered to C$19 from C$20.50 at Raymond James
01/12/22 Scotiabank
TransAlta Renewables price target lowered to C$19 from C$20 at Scotiabank
01/12/22 TD Securities
TransAlta Renewables price target lowered to C$18 from C$19.50 at TD Securities
Hot Stocks
ALX Oncology treatment for gastric cancer granted orphan designation » 11:57
01/27/22
01/27
11:57
01/27/22
11:57
ALXO

ALX Oncology

$14.50 /

+0.01 (+0.07%)

ALX Oncology was granted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALXO ALX Oncology
$14.50 /

+0.01 (+0.07%)

ALXO ALX Oncology
$14.50 /

+0.01 (+0.07%)

12/22/21
Fly Intel: Top five analyst downgrades
12/22/21 Jefferies
ALX Oncology downgraded to Hold on MDS uncertainty at Jefferies
12/22/21 Jefferies
ALX Oncology downgraded to Hold from Buy at Jefferies
12/14/21 Credit Suisse
ALX Oncology price target lowered to $53 from $83 at Credit Suisse
ALXO ALX Oncology
$14.50 /

+0.01 (+0.07%)

Recommendations
Saputo price target lowered to C$36 from C$40 at Scotiabank » 11:56
01/27/22
01/27
11:56
01/27/22
11:56
SAPIF

Saputo

$22.08 /

-0.14 (-0.63%)

Scotiabank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAPIF Saputo
$22.08 /

-0.14 (-0.63%)

SAPIF Saputo
$22.08 /

-0.14 (-0.63%)

01/19/22 National Bank
Saputo price target lowered to C$35 from C$36 at National Bank
11/08/21 Desjardins
Saputo price target lowered to C$37 from C$38 at Desjardins
11/08/21 Scotiabank
Saputo price target lowered to C$40 from C$42 at Scotiabank
11/05/21 CIBC
Saputo price target lowered to C$38 from C$41 at CIBC
Recommendations
Northland Power price target lowered to C$42.25 from C$47.75 at Scotiabank » 11:56
01/27/22
01/27
11:56
01/27/22
11:56
NPIFF

Northland Power

$27.91 /

-0.09 (-0.32%)

Scotiabank analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NPIFF Northland Power
$27.91 /

-0.09 (-0.32%)

NPIFF Northland Power
$27.91 /

-0.09 (-0.32%)

01/16/22 BMO Capital
Northland Power upgraded to Outperform from Market Perform at BMO Capital
01/11/22 CIBC
Northland Power price target lowered to C$43 from C$45 at CIBC
12/02/21 National Bank
Northland Power price target lowered to C$44 from C$48 at National Bank
11/11/21 Scotiabank
Northland Power price target lowered to C$47.75 from C$48.25 at Scotiabank
Hot Stocks
LVMH CEO calls 2021 performance 'remarkable' » 11:56
01/27/22
01/27
11:56
01/27/22
11:56
LVMUY

LVMH

$152.51 /

+0.75 (+0.49%)

Bernard Arnault, Chairman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

01/18/22 Morgan Stanley
LVMH price target raised to EUR 820 from EUR 760 at Morgan Stanley
01/07/22 Evercore ISI
Evercore shifts portfolio to 'value oriented' retail names for 2022
11/30/21 Barclays
LVMH price target raised to EUR 815 from EUR 726 at Barclays
11/05/21 Erste Group
LVMH upgraded to Buy on continued high growth at Erste Group
LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

Syndicate
Credo Technology indicated to open at $12.60, IPO priced at $10  11:55
01/27/22
01/27
11:55
01/27/22
11:55
CRDO

Credo Technology

/

+

 
ShowHide Related Items >><<
  • 27
    Jan
Recommendations
Mountain Province price target raised to C$0.15 from C$0.10 at Scotiabank » 11:55
01/27/22
01/27
11:55
01/27/22
11:55
MPVDF

Mountain Province Diamonds

/

+

Scotiabank analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPVDF Mountain Province Diamonds
/

+

06/11/21 Scotiabank
Mountain Province Diamonds price target raised to C$0.10 at Scotiabank
05/13/21 Scotiabank
Mountain Province Diamonds price target lowered to C$0.05 at Scotiabank
04/01/21 Scotiabank
Mountain Province Diamonds price target lowered to C$0.10 at Scotiabank
Options
Sirius XM put volume heavy and directionally bearish » 11:55
01/27/22
01/27
11:55
01/27/22
11:55
SIRI

Sirius XM

$6.20 /

+0.22 (+3.68%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIRI Sirius XM
$6.20 /

+0.22 (+3.68%)

SIRI Sirius XM
$6.20 /

+0.22 (+3.68%)

01/14/22 JPMorgan
Sirius XM downgraded to Underweight on slowing car sales at JPMorgan
01/13/22 JPMorgan
Sirius XM downgraded to Underweight from Neutral at JPMorgan
01/04/22 Wells Fargo
Wells Fargo downgrades Sirius XM to Equal Weight, lowers price target to $7
01/04/22 Wells Fargo
Sirius XM downgraded to Equal Weight from Overweight at Wells Fargo
SIRI Sirius XM
$6.20 /

+0.22 (+3.68%)

SIRI Sirius XM
$6.20 /

+0.22 (+3.68%)

SIRI Sirius XM
$6.20 /

+0.22 (+3.68%)

SIRI Sirius XM
$6.20 /

+0.22 (+3.68%)

General news
Treasury's $90 B 4- and 8-week bill auctions were mixed » 11:55
01/27/22
01/27
11:55
01/27/22
11:55
$ECON

Economic Data

/

+

Treasury's $90 B 4-…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
LVMH reports 2021 revenue of EUR 64.2B, up 44% year-over-year » 11:54
01/27/22
01/27
11:54
01/27/22
11:54
LVMUY

LVMH

$152.51 /

+0.75 (+0.49%)

LVMH Moet Hennessy Louis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

01/18/22 Morgan Stanley
LVMH price target raised to EUR 820 from EUR 760 at Morgan Stanley
01/07/22 Evercore ISI
Evercore shifts portfolio to 'value oriented' retail names for 2022
11/30/21 Barclays
LVMH price target raised to EUR 815 from EUR 726 at Barclays
11/05/21 Erste Group
LVMH upgraded to Buy on continued high growth at Erste Group
LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

LVMUY LVMH
$152.51 /

+0.75 (+0.49%)

Recommendations
Innergex Renewable price target lowered to C$20.25 from C$26.50 at Scotiabank » 11:53
01/27/22
01/27
11:53
01/27/22
11:53
INGXF

Innergex Renewable Energy

$14.00 /

+0.04 (+0.29%)

Scotiabank analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INGXF Innergex Renewable Energy
$14.00 /

+0.04 (+0.29%)

01/11/22 CIBC
Innergex upgraded to Outperformer on 'bounce back' potential at CIBC
01/10/22 CIBC
Innergex Renewable Energy upgraded to Outperformer from Neutral at CIBC
12/02/21 National Bank
Innergex Renewable price target lowered to C$23 from C$28 at National Bank
11/11/21 CIBC
Innergex Renewable Energy price target lowered to C$22.50 from C$23 at CIBC
Recommendations
Hydro One price target raised to C$32 from C$31 at Scotiabank » 11:51
01/27/22
01/27
11:51
01/27/22
11:51
HRNNF

Hydro One

$25.01 /

-0.46 (-1.81%)

Scotiabank analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRNNF Hydro One
$25.01 /

-0.46 (-1.81%)

01/11/22 CIBC
Hydro One price target raised to C$35 from C$34 at CIBC
11/10/21 RBC Capital
Hydro One price target raised to C$33 from C$32 at RBC Capital
08/20/21 Credit Suisse
Hydro One price target raised to C$33 from C$32 at Credit Suisse
08/12/21 National Bank
Hydro One price target raised to C$32 from C$31 at National Bank
Recommendations
George Weston price target raised to C$167 from C$134 at Scotiabank » 11:50
01/27/22
01/27
11:50
01/27/22
11:50
WNGRF

George Weston

$107.50 /

+2.35 (+2.23%)

Scotiabank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WNGRF George Weston
$107.50 /

+2.35 (+2.23%)

01/21/22 CIBC
George Weston price target lowered to C$171 from C$175 at CIBC
01/06/22 TD Securities
George Weston price target raised to C$175 from C$170 at TD Securities
11/26/21 Desjardins
George Weston price target raised to C$158 from C$141 at Desjardins
11/19/21 RBC Capital
George Weston price target raised to C$162 from C$154 at RBC Capital
Recommendations
Fortis price target raised to C$61 from C$60 at Scotiabank » 11:49
01/27/22
01/27
11:49
01/27/22
11:49
FTS

Fortis

$46.21 /

+0.1 (+0.22%)

Scotiabank analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTS Fortis
$46.21 /

+0.1 (+0.22%)

FTS Fortis
$46.21 /

+0.1 (+0.22%)

01/11/22 CIBC
Fortis price target raised to C$61 from C$58 at CIBC
01/07/22 Scotiabank
Fortis downgraded to Sector Perform on valuation at Scotiabank
01/07/22 Scotiabank
Fortis downgraded to Sector Perform from Outperform at Scotiabank
01/06/22 TD Securities
Fortis downgraded to Buy from Action List Buy at TD Securities
FTS Fortis
$46.21 /

+0.1 (+0.22%)

Recommendations
Boralex price target lowered to C$45.25 from C$51 at Scotiabank » 11:48
01/27/22
01/27
11:48
01/27/22
11:48
BRLXF

Boralex

$25.21 /

+ (+0.00%)

Scotiabank analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRLXF Boralex
$25.21 /

+ (+0.00%)

01/24/22 Credit Suisse
Credit Suisse more bullish on Boralex, upgrades to Outperform
01/24/22 Credit Suisse
Boralex upgraded to Outperform from Neutral at Credit Suisse
01/11/22 CIBC
Boralex price target lowered to C$42 from C$48 at CIBC
12/02/21 National Bank
Boralex price target lowered to C$41 from C$50 at National Bank
Recommendations
Altius Renewable price target lowered to C$12.50 from C$13.50 at Scotiabank » 11:46
01/27/22
01/27
11:46
01/27/22
11:46
ATRWF

Altius Renewable

$7.43 /

+0.14 (+1.92%)

Scotiabank analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATRWF Altius Renewable
$7.43 /

+0.14 (+1.92%)

11/23/21 National Bank
Altius Renewable price target raised to C$13 from C$12.50 at National Bank
10/03/21 National Bank
Altius Renewable upgraded to Outperform from Sector Perform at National Bank
10/01/21 Raymond James
Raymond James upgrades Altius Renewable to Strong Buy on capital deployment
10/01/21 Raymond James
Altius Renewable upgraded to Strong Buy from Outperform at Raymond James
On The Fly
Rising High: Exclusive talk with cannabis REIT NewLake Capital » 11:46
01/27/22
01/27
11:46
01/27/22
11:46
NLCP

NewLake Capital Partners

$25.50 /

+0.25 (+0.99%)

, ACB

Aurora Cannabis

$3.90 /

-0.14 (-3.47%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$7.00 /

-0.22 (-3.05%)

, CRON

Cronos Group

$3.30 /

-0.11 (-3.23%)

, CANN

General Cannabis

/

+

, GDNSF

Goodness Growth

$1.70 /

+0.03 (+1.80%)

, GTBIF

Green Thumb Industries

$18.11 /

-0.32 (-1.74%)

, IGC

India Globalization Capital

/

+

, TLRY

Tilray

$5.31 /

-0.23 (-4.15%)

, TCNNF

Trulieve Cannabis

$19.50 /

-0.5 (-2.50%)

, ZYNE

Zynerba

$2.44 /

+0.035 (+1.46%)

, ATAI

Atai Life Sciences

$4.86 /

-0.015 (-0.31%)

, CMPS

Compass Pathways

$14.60 /

-0.61 (-4.01%)

, RLMD

Relmada Therapeutics

$18.10 /

-0.35 (-1.90%)

In this edition of…

ShowHide Related Items >><<
NLCP NewLake Capital Partners
$25.50 /

+0.25 (+0.99%)

ACB Aurora Cannabis
$3.90 /

-0.14 (-3.47%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CGC Canopy Growth
$7.00 /

-0.22 (-3.05%)

CRON Cronos Group
$3.30 /

-0.11 (-3.23%)

CANN General Cannabis
/

+

GDNSF Goodness Growth
$1.70 /

+0.03 (+1.80%)

GTBIF Green Thumb Industries
$18.11 /

-0.32 (-1.74%)

IGC India Globalization Capital
/

+

TLRY Tilray
$5.31 /

-0.23 (-4.15%)

TCNNF Trulieve Cannabis
$19.50 /

-0.5 (-2.50%)

ZYNE Zynerba
$2.44 /

+0.035 (+1.46%)

ATAI Atai Life Sciences
$4.86 /

-0.015 (-0.31%)

CMPS Compass Pathways
$14.60 /

-0.61 (-4.01%)

RLMD Relmada Therapeutics
$18.10 /

-0.35 (-1.90%)

NLCP NewLake Capital Partners
$25.50 /

+0.25 (+0.99%)

09/08/21 Compass Point
NewLake Capital Partners initiated with a Buy at Compass Point
09/07/21 Ladenburg
NewLake Capital Partners initiated with a Buy at Ladenburg
ACB Aurora Cannabis
$3.90 /

-0.14 (-3.47%)

11/11/21 Canaccord
Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord
11/10/21 CIBC
Aurora Cannabis upgraded to Neutral from Underperformer at CIBC
09/29/21 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$7 at CIBC
09/28/21 MKM Partners
Aurora Cannabis upgraded to Neutral from Sell at MKM Partners
CVSI CV Sciences
/

+

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
CTST CannTrust
/

+

CGC Canopy Growth
$7.00 /

-0.22 (-3.05%)

01/06/22 Alliance Global Partners
Canopy Growth price target lowered to C$11 from C$18 at Alliance Global Partners
01/04/22 Wells Fargo
Constellation Brands price target raised to $300 from $265 at Wells Fargo
12/22/21
Fly Intel: Top five analyst downgrades
12/22/21 BofA
Canopy Growth downgraded to Underperform from Neutral at BofA
CRON Cronos Group
$3.30 /

-0.11 (-3.23%)

08:39 Today Jefferies
Jefferies upgrades Cronos to Hold with stock 'not too far off' cash value
04:46 Today Jefferies
Cronos Group upgraded to Hold from Underperform at Jefferies
11/18/21 Barclays
Cronos Group initiated with an Underweight at Barclays
11/18/21 BofA
Cronos Group transferred with Underpeform rating at BofA
CANN General Cannabis
/

+

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
GDNSF Goodness Growth
$1.70 /

+0.03 (+1.80%)

11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
GTBIF Green Thumb Industries
$18.11 /

-0.32 (-1.74%)

01/06/22 Wolfe Research
Green Thumb Industries initiated with an Outperform at Wolfe Research
11/11/21 Canaccord
Green Thumb Industries price target lowered to C$53 from C$56 at Canaccord
11/11/21 Craig-Hallum
Green Thumb Industries price target lowered to $50 from $60 at Craig-Hallum
11/11/21 Cantor Fitzgerald
Green Thumb Industries price target raised to $54 from $38 at Cantor Fitzgerald
IGC India Globalization Capital
/

+

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
TLRY Tilray
$5.31 /

-0.23 (-4.15%)

01/11/22 MKM Partners
Tilray price target lowered to $8 from $10 at MKM Partners
01/11/22 Canaccord
Tilray price target lowered to $9 from $12 at Canaccord
01/10/22 Alliance Global Partners
Tilray price target raised to $8 from $7 at Alliance Global Partners
01/10/22 Stifel
Tilray sales underperformed 'muted expectations,' says Stifel
TCNNF Trulieve Cannabis
$19.50 /

-0.5 (-2.50%)

01/06/22 Wolfe Research
Trulieve Cannabis initiated with an Outperform at Wolfe Research
12/28/21 Alliance Global Partners
AGP says cannabis fight heats up in Arizona with Curaleaf, Trulieve deals
12/06/21 Cantor Fitzgerald
Trulieve Cannabis price target lowered to $72 from $73 at Cantor Fitzgerald
11/01/21 Stifel
Trulieve Cannabis price target raised to C$135 from C$132 at Stifel
ZYNE Zynerba
$2.44 /

+0.035 (+1.46%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
ATAI Atai Life Sciences
$4.86 /

-0.015 (-0.31%)

11/30/21
Fly Intel: Top five analyst initiations
11/30/21 Maxim
Atai Life Sciences initiated with a Buy at Maxim
11/30/21 Maxim
Atai Life Sciences initiated with a Buy at Maxim
11/22/21 Canaccord
Atai Life Sciences weakness a buying opportunity, says Canaccord
CMPS Compass Pathways
$14.60 /

-0.61 (-4.01%)

11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
11/09/21 Roth Capital
Compass Pathways price target raised to $117 from $79 at Roth Capital
RLMD Relmada Therapeutics
$18.10 /

-0.35 (-1.90%)

12/20/21 SVB Leerink
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
07/28/21 Truist
Relmada Therapeutics price target raised to $90 from $75 at Truist
NLCP NewLake Capital Partners
$25.50 /

+0.25 (+0.99%)

ACB Aurora Cannabis
$3.90 /

-0.14 (-3.47%)

CVSI CV Sciences
/

+

CGC Canopy Growth
$7.00 /

-0.22 (-3.05%)

CRON Cronos Group
$3.30 /

-0.11 (-3.23%)

GTBIF Green Thumb Industries
$18.11 /

-0.32 (-1.74%)

TLRY Tilray
$5.31 /

-0.23 (-4.15%)

ZYNE Zynerba
$2.44 /

+0.035 (+1.46%)

ATAI Atai Life Sciences
$4.86 /

-0.015 (-0.31%)

CMPS Compass Pathways
$14.60 /

-0.61 (-4.01%)

RLMD Relmada Therapeutics
$18.10 /

-0.35 (-1.90%)

  • 09
    Dec
  • 18
    Jun
  • 30
    Apr
ACB Aurora Cannabis
$3.90 /

-0.14 (-3.47%)

CVSI CV Sciences
/

+

CGC Canopy Growth
$7.00 /

-0.22 (-3.05%)

CRON Cronos Group
$3.30 /

-0.11 (-3.23%)

CANN General Cannabis
/

+

GDNSF Goodness Growth
$1.70 /

+0.03 (+1.80%)

GTBIF Green Thumb Industries
$18.11 /

-0.32 (-1.74%)

IGC India Globalization Capital
/

+

TLRY Tilray
$5.31 /

-0.23 (-4.15%)

TCNNF Trulieve Cannabis
$19.50 /

-0.5 (-2.50%)

ZYNE Zynerba
$2.44 /

+0.035 (+1.46%)

CMPS Compass Pathways
$14.60 /

-0.61 (-4.01%)

ACB Aurora Cannabis
$3.90 /

-0.14 (-3.47%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CGC Canopy Growth
$7.00 /

-0.22 (-3.05%)

CRON Cronos Group
$3.30 /

-0.11 (-3.23%)

CANN General Cannabis
/

+

GDNSF Goodness Growth
$1.70 /

+0.03 (+1.80%)

GTBIF Green Thumb Industries
$18.11 /

-0.32 (-1.74%)

IGC India Globalization Capital
/

+

TLRY Tilray
$5.31 /

-0.23 (-4.15%)

TCNNF Trulieve Cannabis
$19.50 /

-0.5 (-2.50%)

ZYNE Zynerba
$2.44 /

+0.035 (+1.46%)

ATAI Atai Life Sciences
$4.86 /

-0.015 (-0.31%)

CMPS Compass Pathways
$14.60 /

-0.61 (-4.01%)

RLMD Relmada Therapeutics
$18.10 /

-0.35 (-1.90%)

ACB Aurora Cannabis
$3.90 /

-0.14 (-3.47%)

CGC Canopy Growth
$7.00 /

-0.22 (-3.05%)

CRON Cronos Group
$3.30 /

-0.11 (-3.23%)

IGC India Globalization Capital
/

+

TLRY Tilray
$5.31 /

-0.23 (-4.15%)

ATAI Atai Life Sciences
$4.86 /

-0.015 (-0.31%)

CMPS Compass Pathways
$14.60 /

-0.61 (-4.01%)

Recommendations
AltaGas price target raised to C$31 from C$30 at Scotiabank » 11:45
01/27/22
01/27
11:45
01/27/22
11:45
ATGFF

AltaGas

$20.29 /

+0.02 (+0.10%)

Scotiabank analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATGFF AltaGas
$20.29 /

+0.02 (+0.10%)

ATGFF AltaGas
$20.29 /

+0.02 (+0.10%)

01/26/22 National Bank
AltaGas price target raised to C$31 from C$29 at National Bank
01/11/22 CIBC
AltaGas price target raised to C$34 from C$30 at CIBC
01/06/22 TD Securities
AltaGas price target raised to C$30 from C$29 at TD Securities
12/16/21 BMO Capital
AltaGas price target raised to C$34 from C$30.50 at BMO Capital
Recommendations
AGF Management price target raised to C$10 from C$9.50 at Scotiabank » 11:44
01/27/22
01/27
11:44
01/27/22
11:44
AGFMF

AGF Management

$6.17 /

+ (+0.00%)

Scotiabank analyst Phil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGFMF AGF Management
$6.17 /

+ (+0.00%)

AGFMF AGF Management
$6.17 /

+ (+0.00%)

11:41 Today TD Securities
AGF Management price target lowered to C$9 from C$9.50 at TD Securities
01/25/22 Scotiabank
AGF Management price target lowered to C$9.50 from C$10.50 at Scotiabank
10/26/21 Scotiabank
AGF Management price target raised to C$10.50 from C$9 at Scotiabank
10/01/21 Desjardins
AGF Management price target raised to C$10.75 from C$10.50 at Desjardins
AGFMF AGF Management
$6.17 /

+ (+0.00%)

Recommendations
Goeasy price target lowered to C$240 from C$260 at TD Securities » 11:41
01/27/22
01/27
11:41
01/27/22
11:41
EHMEF

Goeasy

$120.26 /

-0.01 (-0.01%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EHMEF Goeasy
$120.26 /

-0.01 (-0.01%)

EHMEF Goeasy
$120.26 /

-0.01 (-0.01%)

01/13/22 BMO Capital
Goeasy price target raised to C$228 from C$226 at BMO Capital
11/29/21 Scotiabank
Goeasy initiated with a Sector Perform at Scotiabank
11/08/21 Desjardins
Goeasy price target lowered to C$200 from C$202 at Desjardins
11/05/21 National Bank
Goeasy price target raised to C$220 from C$196 at National Bank
Recommendations
AGF Management price target lowered to C$9 from C$9.50 at TD Securities » 11:41
01/27/22
01/27
11:41
01/27/22
11:41
AGFMF

AGF Management

$6.17 /

+ (+0.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGFMF AGF Management
$6.17 /

+ (+0.00%)

AGFMF AGF Management
$6.17 /

+ (+0.00%)

01/25/22 Scotiabank
AGF Management price target lowered to C$9.50 from C$10.50 at Scotiabank
10/26/21 Scotiabank
AGF Management price target raised to C$10.50 from C$9 at Scotiabank
10/01/21 Desjardins
AGF Management price target raised to C$10.75 from C$10.50 at Desjardins
09/21/21 Desjardins
AGF Management price target raised to C$10.50 from C$9.75 at Desjardins
AGFMF AGF Management
$6.17 /

+ (+0.00%)

General news
8-week bill auction » 11:40
01/27/22
01/27
11:40
01/27/22
11:40
$ECON

Economic Data

/

+

Total Amount: $40B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
4-week bill auction » 11:40
01/27/22
01/27
11:40
01/27/22
11:40
$ECON

Economic Data

/

+

Total Amount: $50B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
BTIG fixed income analysts to hold an analyst/industry conference call » 11:36
01/27/22
01/27
11:36
01/27/22
11:36

Fixed Income Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.